GSK Vaccine Vet Pfefer Tapped for Executive Roles at Flagship, Kintai
Flagship Pioneering has appointed Guillaume Pfefer to serve as CEO-partner of the venture capital firm. He will also become CEO of Kintai Therapeutics, one of the Cambridge, MA-based firm’s portfolio companies. Pfefer worked most recently at GlaxoSmithKline (NYSE: GSK), where he was senior vice president and global vaccine leader for Shingrix, the company’s shingles vaccine. […]